Coon CD, Bokowy KL, Horblyuk R, Zisman RS, McLeod LD, Brown MT. The development and initial assessment of the strategy and leadership systems capability evaluation survey. Health Care Manag (Frederick). 2012 Oct 1;31(4):332-41.
Baillie L, Hawe E. Causes of death: a study of a century of change in England and Wales. 2012. Office of Health Economics.
Zografos L. Considerations for implementing surveys evaluating effectiveness: sample recruitment, ethics, and privacy. Presented at the 28th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; September 5, 2012. Barcelona.
Huybrechts KF, Seeger JD, Rothman KJ, Glynn RJ, Avorn J, Schneeweiss S. Bias in comparative effectiveness studies due to regional variation in medical practice intensity: a legitimate concern, or much ado about nothing? Circ Cardiovasc Qual Outcomes. 2012 Sep 1;5(5):e61-4.
Riera-Guardia N, Saltus C, Bui C, Harris DH, Kaye JA, Tennis P, Castellsague J, Perez-Gutthann S. Back in Barcelona: the landscape of database research over the last decade. Poster presented at the 28th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 27, 2012. Barcelona. [abstract] Pharmacoepidemiol Drug Saf. 21(Suppl 3):S306-7.
Afonso A, Prieto-Alhambra D, Escudero Garcia A, Estany Gestal A, Martin-Merino E, Riera Guardia N, Lopez-Leon S, Perez-Gutthann S, Hernández-Díaz S. FarmacoEpiEnRed, a network for pharmacoepidemiology in Spain. Poster presented at the 28th International Conference on Pharmacoepidemiology; August 27, 2012. Barcelona, Spain. [abstract] Pharmacoepidemiol Drug Saf. 2012 Aug 27; 21(Suppl 3):193. doi: 10.1002/pds.3324
Vidrine DJ, Fletcher FE, Danysh HE, Marani S, Vidrine JI, Cantor SB, Prokhorov AV. A randomized controlled trial to assess the efficacy of an interactive mobile messaging intervention for underserved smokers: project ACTION. BMC Public Health. 2012 Aug 25;12:696. doi: 10.1186/1471-2458-12-696
Poulos C, Yang JC, Patil SR, Pattanayak S, Wood S, Goodyear L, Gonzalez JM. Consumer preferences for household water treatment products in Andhra Pradesh, India. Soc Sci Med. 2012 Aug 1;75(4):738-46.
Lunt M, Wyss R, Glynn R, Poole C, Rothman KJ. An example in which omitting an instrumental variable from a propensity score leads to a biased estimate of the effect of an exposure. Poster presented at the 28th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2012. Barcelona, Spain. [abstract] Pharmacoepidemiol Drug Saf. 2012 Aug; 21(Supp 3):125-6.
Launois R, Le Moine JG, Lozano FS, Mansilha A. Construction and international validation of CIVIQ-14 (a short form of CIVIQ-20), a new questionnaire with a stable factorial structure. Qual Life Res. 2012 Aug;21(6):1051-8. doi: 10.1007/s11136-011-0008-3
Mauskopf JA, Candrilli SD, Chevrou-Severac H, Ochoa JB. Immunonutrition for patients undergoing elective surgery for gastrointestinal cancer: impact on hospital costs. World J Surg Oncol. 2012 Jul 1;10:136.
Hegedus LL, Rothman KJ, Rodes C, Bann CM, Trainham JA. RTI Research Futures. 2012. NC. Research Triangle Park.
Rassen JA, Glynn RJ, Rothman KJ, Setoguchi S, Schneeweiss S. Response to commentary by Marcus and Gibbons. Pharmacoepidemiol Drug Saf. 2012 Jul;21(7):713.
Rassen JA, Glynn RJ, Rothman KJ, Setoguchi S, Schneeweiss S. Applying propensity scores estimated in a full cohort to adjust for confounding in subgroup analyses. Pharmacoepidemiol Drug Saf. 2012 Jul 1;21(7):697-709.
Hartley L, Girling A, Bowater R, Lilford R. Inter-continental differences in the clinical effectiveness of medical interventions: a study using panoramic meta-analysis. Presented at the Department of Health Sciences Seminar at the University of Warwick; June 19, 2012. Coventry, United Kingdom.
DiBenedetti DB, Lewis SA, Price MA. The role of cognitive pretesting interviews in REMS survey development. Poster presented at the Risk Evaluation and Mitigation Strategy (REMS) Assessments: Social Science Methodologies to Assess Goals Related to Knowledge Public Workshop; June 7, 2012.
Petrillo J, Cano S, McLeod LD, Coon CD. What is the value of classical test theory, item response theory, and Rasch measurement theory in the development of patient-reported outcome instruments? Presented at the 2012 ISPOR 17th Annual International Meeting; June 2012. Washington, DC.
Gnanasakthy A, Lewis SA, Clark MJ, Mordin MM, Evans E, DeMuro-Mercon CJ. The impact of primary endpoints on patient-reported outcome label claims. Poster presented at the 2012 ISPOR 17th Annual International Meeting; June 2012.
Mladsi DM, Graham JB, Ronquest NA. Trade-off analysis: an extension of threshold pricing analysis. Poster presented at the 2012 ISPOR 17th Annual International Meeting; June 7, 2012. Washington, DC. [abstract] Value Health. 2012 Jun; 15(4):A169.
Nelson LM, Stull DE, Coon CD, Gnanasakthy A. Use of latent growth modeling to evaluate construct validity in longitudinal studies. Presented at the 2012 ISPOR 17th Annual International Meeting; June 2012. Washington, DC.
Mladsi D, Herring WL, Earnshaw S. Cost-effectiveness analysis in personalized medicine: general hypotheses and corresponding decision tree structures for screening, diagnostic, predictive, prognostic, surveillance, and monitoring tests. Poster presented at the 2012 ISPOR 17th Annual International Meeting; June 7, 2012. Washington, DC. [abstract] Value Health. 2012 Jun; 15(4):A168-9.
DeMuro C, Clark M, Coon C, Evans E, Mordin M, Gnanasakthy A. Assessment of PRO labels claims granted by the FDA as compared to the EMA. Poster presented at the 2012 ISPOR 17th Annual International Meeting; June 2012. Washington, DC. [abstract] Value Health. 2012 Jun; 15(4):A201. doi: 10.1016/j.jval.2012.03.1085
Mansfield CA. Valuing a real (and controversial) proposal through a stated-preference survey. Presented at the Summer Workshop of the Association of Environmental and Resource Economists; June 2012. Asheville, NC.
Lunt M, Glynn RJ, Rothman KJ, Avorn J, Sturmer T. Propensity score calibration in the absence of surrogacy. Am J Epidemiol. 2012 Jun 1;175(12):1294-302.
Gnanasakthy A, Sadrick A, DeMuro C, Rahul R. Promotion of patient reported outcomes (PRO) label claims based on non-primary endpoints. Poster presented at the 2012 ISPOR 17th Annual International Meeting; June 2012. Washington, DC. [abstract] Value Health. 2012 Jun; 15(4):A201. doi: 10.1016/j.jval.2012.03.1086
Gnanasakthy A, Lewis S, Clark M, Evans E, Mordin M, DeMuro C. Reported outcomes as primary endpoints in confirmatory clinical trials. Poster presented at the 2012 ISPOR 17th Annual International Meeting; June 2012. Washington, DC. [abstract] Value Health. 2012 Jun; 15(4):A200.
Rassen JA, Shelat AA, Myers J, Glynn RJ, Rothman KJ, Schneeweiss S. One-to-many propensity score matching in cohort studies. Pharmacoepidemiol Drug Saf. 2012 May 1;21(Suppl. 2):69-80.
DeMuro C, Clark M, Mordin M, Fehnel S, Copley-Merriman C, Gnanasakthy A. Reasons for rejection of patient-reported outcome label claims: a compilation based on a review of patient-reported outcome use among new molecular entities and niologic license applications, 2006-2010. Value Health. 2012 May 1;15(3):443-8.
Gnanasakthy A, Mordin M, Clark M, DeMuro C, Fehnel S, Copley-Merriman C. A review of patient-reported outcome labels in the United States: 2006 to 2010. Value Health. 2012 May;15(3):437-42. doi: 10.1016/j.jval.2011.11.032
DeMuro CJ, Lewis SA, DiBenedetti DB, Price MA, Fehnel SE. Successful implementation of cognitive interviews in special populations. Expert Rev Pharmacoecon Outcomes Res. 2012 Apr 1;12(2):181-7.
Herring WL, Herrmann JW. The single-day surgery scheduling problem: sequential decision-making and threshold-based heuristics. OR spectrum: quantitative approaches in management. 2012 Apr 1;34(2):429-59.
Arana A, Arana JI. Medical diagnostic theory applied to food technology. In: Arana, I, editors. Physical properties of foods: novel measurement techniques and applications. Boca Raton: FL. CRC Press; 2012. doi: 10.1201/b11542-10
Arana A, Arana I. Medical diagnostic theory applied to food technology. Boca Raton: FL. CRC Press; 2012.
Bernfort L, Brodtkorb T. QALY som effektmått inom vården : möjligheter och begränsningar. Linköping: linköping University Electronic Press. Cmt- Rapport. 2012.
Rassen JA, Shelat AA, Myers J, Glynn RJ, Rothman KJ, Schneeweiss S. Optimal approaches to one-to-many propensity score matching in cohort studies. Pharmacoepidemiol Drug Saf. 2012;21(Supp 3):S34-5.
Hareendran A, Gnanasakthy A, Winnette RM, Revicki D. Capturing patients' perspectives of treatment in clinical trials/drug development. Contemp Clin Trials. 2012 Jan;33(1):23-8.
Myers JA, Rassen JA, Gagne JJ, Huybrechts KF, Schneeweiss S, Rothman KJ, Glynn RJ. Myers et al. respond to "understanding bias amplification". Am J Epidemiol. 2011 Dec;174(11):1228-9.
Myers JA, Rassen JA, Gagne JJ, Huybrechts KF, Schneeweiss S, Rothman KJ, Joffe MM, Glynn RJ. Effects of adjusting for instrumental variables on bias and precision of effect estimates. Am J Epidemiol. 2011 Dec 1;174(11):1213-22.
Herring WL, Herrmann JW. A stochastic dynamic program for the single-day surgery scheduling problem. IIE Trans Healthc Syst Eng. 2011 Dec 1;1(4):213-25.
Hong J, Reed C, Novick D, Haro JM, Aguado J. Clinical and economic consequences of medication non-adherence in the treatment of patients with a manic/mixed episode of bipolar disorder: results from the European Mania in Bipolar Longitudinal Evaluation of Medication (EMBLEM) study. Psychiatry Research. 2011 Nov 30;190(1):110-4.
Stull DE, Houghton KF, Kulich K. Innovative methods for demonstrating value for pharmaceutical products: rethinking data analysis with implications for study design and personalized medicine. Presented at the International Society for Pharmacoeconomics and Outcomes Research; November 5, 2011. Madrid, Spain.
Walter JW, Spinner DS, Birt J, Bowman L, Mauskopf JA, Drummond M, Copley-Merriman K. Clinical and economic evidence bases for health technology assessment: a comparison of three jurisdictions. Poster presented at the 2011 ISPOR 14th Annual European Congress; November 2011. Madrid, Spain.
Baillie L, Hawe E, O'Neill P, Greville R. Health and the use of medicines in primary care in Wales. November 2011 ed. London: United Kingdom. OHE Consulting Report; 2011.
Hicks KA, Karve S, Vlahiotis A, Frazee S, Tian Y, Earnshaw SR. Estimation of increases in direct medical expenditures associated with medication nonadherence and potential savings from increased adherence. Poster presented at the 2011 ISPOR 14th Annual European Congress; November 9, 2011. [abstract] Value Health. 2011 Nov; 14(7):A343-4.
McLeod LD, Williams VS, Nelson LM, Coon CD. Psychometrics for the non-psychometrician – part I. Presented at the 18th Annual Conference of the International Society for Quality of Life Research; October 2011.
Nelson LM, Nixon A, Copley-Merriman K. Documenting PRO evidence for regulatory submissions to support labeling claims. Poster presented at the International Society for Quality of Life Research Workshop #2; October 2011.
Coon CD, Nelson LM, McLeod LD, Williams VS. Psychometrics for the non-psychometrician – part II. Presented at the 18th Annual Conference of the International Society for Quality of Life Research; October 2011.
Swartz RJ, Schwartz C, Basch E, Cai L, Fairclough DL, McLeod L, Mendoza TR, Rapkin B. The king's foot of patient-reported outcomes: current practices and new developments for the measurement of change. Qual Life Res. 2011 Oct 1;20(8):1159-67.